Filing Details
- Accession Number:
- 0000950170-24-135521
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-11 18:44:06
- Reporting Period:
- 2024-12-09
- Accepted Time:
- 2024-12-11 18:44:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1515673 | Ultragenyx Pharmaceutical Inc. | RARE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1248093 | D Emil Kakkis | C/O Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949 | President & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-12-09 | 20,000 | $0.00 | 2,203,985 | No | 4 | G | Indirect | By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009 |
| Common Stock | Disposition | 2024-12-10 | 8,273 | $50.00 | 2,195,712 | No | 4 | S | Indirect | By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | G | Indirect | By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009 |
| No | 4 | S | Indirect | By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009 |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 564,605 | Direct |
Footnotes
- Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- Includes 8 shares acquired under the Company's A&R 2014 Employee Stock Purchase Plan on October 31, 2024.
Billionaire Hedge Funds
